As a researcher at a US institute between 1978 and 1992, Roberts realised that a type of restrictive enzyme they were making was in high demand among scientists. He went to the then director of the institute with an offer to commercialise it. The director turned it down. This led Roberts to take it to a small company. The company, New England Biolabs, where he still works, now is one of the global leaders in the discovery and production of enzymes for molecular biology applications.
For researchers who want to commercialise their product, he has some tips.
Denne historien er fra November 16, 2022-utgaven av The Times of India Hyderabad.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra November 16, 2022-utgaven av The Times of India Hyderabad.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på